{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:01:15Z","timestamp":1765382475868,"version":"3.41.2"},"reference-count":52,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323991834"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.irn.2023.12.002","type":"book-chapter","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T15:06:05Z","timestamp":1705331165000},"page":"211-230","source":"Crossref","is-referenced-by-count":1,"title":["Review: Lower urinary tract dysfunction in animal models of Parkinson\u2019s disease (PD): Translational aspects for the treatment of PD patients with overactive bladder"],"prefix":"10.1016","member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/bs.irn.2023.12.002_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0304-3940(88)90143-7","article-title":"Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"87","author":"Albanese","year":"1988","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/nau.21108","article-title":"Rodent models for urodynamic investigation","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib3","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","article-title":"Voiding dysfunction and Parkinson\u2019s disease: Urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"The Journal of Urology"},{"issue":"3","key":"10.1016\/bs.irn.2023.12.002_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nau.1930120302","article-title":"Effects of apomorphine and L-dopa on the parkinsonian bladder","volume":"12","author":"Aranda","year":"1993","journal-title":"Neurourology and Urodynamics"},{"issue":"12","key":"10.1016\/bs.irn.2023.12.002_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2023.12.002_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ucl.2017.04.008","article-title":"Parkinson\u2019s disease and its effect on the lower urinary tract: Evaluation of complications and treatment strategies","volume":"44","author":"Brucker","year":"2017","journal-title":"The Urologic Clinics of North America"},{"issue":"8","key":"10.1016\/bs.irn.2023.12.002_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.parkreldis.2014.04.020","article-title":"Rasagiline effect on bladder disturbances in early mild Parkinson\u2019s disease patients","volume":"20","author":"Brusa","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2023.12.002_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mdc3.12488","article-title":"Rotigotine effects on bladder function in patients with Parkinson\u2019s disease","volume":"4","author":"Brusa","year":"2017","journal-title":"Movement Disorders Clinical Practice"},{"issue":"18","key":"10.1016\/bs.irn.2023.12.002_bib9","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000260605.12506.86","article-title":"Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease","volume":"68","author":"Brusa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2023.12.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116625","article-title":"Extended release levodopa at bedtime as a treatment for nocturiain Parkinson\u2019s disease: An open label study","volume":"410","author":"Brusa","year":"2020","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/j.2040-4603.2015.tb00596.x","article-title":"Neural control of the lower urinary tract","volume":"5","author":"de Groat","year":"2015","journal-title":"Comprehensive Physiology"},{"issue":"6","key":"10.1016\/bs.irn.2023.12.002_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/dneu.20978","article-title":"Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice","volume":"72","author":"Hamill","year":"2012","journal-title":"Developmental Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1254\/jphs.92.143","article-title":"Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats","volume":"92","author":"Hashimoto","year":"2003","journal-title":"Journal of Pharmacological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000047962","article-title":"Downregulation of striatal dopamine D2 receptors in advanced Parkinson\u2019s disease contributes to the development of motor fluctuation","volume":"47","author":"Hwang","year":"2002","journal-title":"European Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2023.12.002_bib15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0022-5347(01)66926-X","article-title":"Effects of neurokinin receptor antagonists on L-dopa induced bladder hyperactivity in normal conscious rats","volume":"154","author":"Ishizuka","year":"1995","journal-title":"The Journal of Urology"},{"key":"10.1016\/bs.irn.2023.12.002_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson\u2019s disease: Their ability to reproduce the features of clinical disease and model gene-environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Experimental Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib18","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.juro.2011.12.062","article-title":"Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease","volume":"187","author":"Kitta","year":"2012","journal-title":"The Journal of Urology"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/iju.13471","article-title":"Benefits and limitations of animal models in partial bladder outlet obstruction for translational research","volume":"25","author":"Kitta","year":"2018","journal-title":"International Journal of Urology: Official Journal of the Japanese Urological Association"},{"issue":"18","key":"10.1016\/bs.irn.2023.12.002_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186520","article-title":"Animal model for lower urinary tract dysfunction in Parkinson\u2019s disease","volume":"21","author":"Kitta","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2023.12.002_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0000000000000281","article-title":"Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson disease patients","volume":"41","author":"Kitta","year":"2018","journal-title":"Clinical Neuropharmacology"},{"issue":"10","key":"10.1016\/bs.irn.2023.12.002_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/iju.13160","article-title":"Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson\u2019s disease","volume":"23","author":"Kitta","year":"2016","journal-title":"International Journal of Urology: Official Journal of the Japanese Urological Association"},{"issue":"3","key":"10.1016\/bs.irn.2023.12.002_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parkreldis.2003.08.001","article-title":"Effects of pergolide on nocturia in Parkinson\u2019s disease: Three female cases selected from over 400 patients","volume":"10","author":"Kuno","year":"2004","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2023.12.002_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","article-title":"Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter","volume":"8","author":"Matsuoka","year":"2001","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2023.12.002_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson\u2019s disease: Prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: From structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiological Reviews"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-140509","article-title":"Local change in urinary bladder contractility following CNS dopamine denervation in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"5","author":"Mitra","year":"2015","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrurol.2016.254","article-title":"Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy","volume":"14","author":"Ogawa","year":"2017","journal-title":"Nature Reviews Urology"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/nau.20260","article-title":"Dopaminergic mechanisms controlling urethral function in rats","volume":"25","author":"Ogawa","year":"2006","journal-title":"Neurourology and Urodynamics"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib30","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41598-022-08612-3","article-title":"Mechanisms of D1\/D2-like dopaminergic agonist, rotigotine, on lower urinary tract function in rat model of Parkinson\u2019s disease","volume":"12","author":"Ouchi","year":"2022","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/nau.23989","article-title":"Dopaminergic urethral closure mechanisms in a rat model of Parkinson\u2019s disease","volume":"38","author":"Ouchi","year":"2019","journal-title":"Neurourology and Urodynamics"},{"key":"10.1016\/bs.irn.2023.12.002_bib32","first-page":"9131474","article-title":"Update on the management of Parkinson\u2019s disease for general neurologists","volume":"2020","author":"Pirtosek","year":"2020","journal-title":"Parkinsons Disease"},{"issue":"5321","key":"10.1016\/bs.irn.2023.12.002_bib33","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N. Y.)"},{"issue":"12","key":"10.1016\/bs.irn.2023.12.002_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243452","article-title":"The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections","volume":"15","author":"Praveen Rajneesh","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2023.12.002_bib35","article-title":"A time-course study of urodynamic analyses in rat models with dopaminergic depletion induced through unilateral and bilateral 6-hydroxydopamine injections","author":"Rajneesh","year":"2022","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"issue":"22","key":"10.1016\/bs.irn.2023.12.002_bib36","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1001\/jama.1987.03390220074024","article-title":"Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients","volume":"257","author":"Resnick","year":"1987","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.71.5.600","article-title":"Videourodynamic and sphincter motor unit potential analyses in Parkinson\u2019s disease and multiple system atrophy","volume":"71","author":"Sakakibara","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10286-017-0480-0","article-title":"Urological dysfunction in synucleinopathies: Epidemiology, pathophysiology and management","volume":"28","author":"Sakakibara","year":"2018","journal-title":"Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society"},{"issue":"8649","key":"10.1016\/bs.irn.2023.12.002_bib39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell and Tissue Research"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","article-title":"Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats","volume":"20","author":"Seki","year":"2001","journal-title":"Neurourology and Urodynamics"},{"issue":"3-4","key":"10.1016\/bs.irn.2023.12.002_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotoxicity Research"},{"issue":"4","key":"10.1016\/bs.irn.2023.12.002_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/nau.20512","article-title":"Comparison of cystometric methods in female rats","volume":"27","author":"Smith","year":"2008","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"10.1016\/bs.irn.2023.12.002_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/mds.10403","article-title":"Short-term effect of a single levodopa dose on micturition disturbance in Parkinson\u2019s disease patients with the wearing-off phenomenon","volume":"18","author":"Uchiyama","year":"2003","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"European Journal of Pharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2023.12.002_bib46","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1468-1331.2007.01982.x","article-title":"Autonomic dysfunction in 3414 Parkinson\u2019s disease patients enrolled in the German Network on Parkinson\u2019s disease (KNP e.V.): The effect of ageing","volume":"14","author":"Wullner","year":"2007","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12883-021-02153-4","article-title":"Evaluation of neurogenic bladder outlet obstruction mimicking sphincter bradykinesia in male patients with Parkinson\u2019s disease","volume":"21","author":"Xing","year":"2021","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2023.12.002_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11255-011-9969-y","article-title":"Urinary tract dysfunction in Parkinson\u2019s disease: A review","volume":"44","author":"Yeo","year":"2012","journal-title":"International Urology and Nephrology"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/exnr.2001.7833","article-title":"Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats","volume":"173","author":"Yokoyama","year":"2002","journal-title":"Experimental Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2023.12.002_bib50","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","article-title":"Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway","volume":"139","author":"Yoshimura","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2023.12.002_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0028-3908(93)90151-R","article-title":"The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"32","author":"Yoshimura","year":"1993","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2023.12.002_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(24)37579-2","article-title":"Therapeutic effects of dopamine D1\/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys","volume":"286","author":"Yoshimura","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["International Review of Neurobiology","Translational Approaches to Unravelling Non-Motor Symptoms of Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T12:49:38Z","timestamp":1753966178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774223001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780323991834"],"references-count":52,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2023.12.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2024]]}}}